- In confirmed cases of a PE, parenteral anticoagulant therapy should be started
- The risk of recurrent PE without treatment can be as high as 25%
- Low molecular weight heparin is recommended for most hemodynamically stable patients
- Intravenous unfractionated heparin is used more in unstable patients and patients with a higher risk of bleeding
| | |